![ChiIL Live Shows: Lookingglass Theatre Company Announces Tickets on Sale Now for the World Premiere of VILLETTE February 8 – April 23, 2023 ChiIL Live Shows: Lookingglass Theatre Company Announces Tickets on Sale Now for the World Premiere of VILLETTE February 8 – April 23, 2023](https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhczF_xYOXVJuj9qjZNPLumnSSBckMdAXZISeAFG2Qe35cFMiK-gCxZ0JSuhpEZc20tvvvWzdMil-zwCei71NidUau-0-Rh4HIQfJ4SiHa6ypu1yUa2iavVWYtT3Lj1bytsAW23zNVnbRFpFDciVk6KGh1wABlL7B60DR4MrZZGMmr45LXZS7rVicuE/s1169/318475420_520644683437521_6202243024924790849_n.jpg)
ChiIL Live Shows: Lookingglass Theatre Company Announces Tickets on Sale Now for the World Premiere of VILLETTE February 8 – April 23, 2023
![Single-cell profiling of alveolar rhabdomyosarcoma reveals RAS pathway inhibitors as cell-fate hijackers with therapeutic relevance | Science Advances Single-cell profiling of alveolar rhabdomyosarcoma reveals RAS pathway inhibitors as cell-fate hijackers with therapeutic relevance | Science Advances](https://www.science.org/cms/10.1126/sciadv.ade9238/asset/00403365-6d8e-43c2-a023-efb4d382b1bd/assets/images/large/sciadv.ade9238-f4.jpg)
Single-cell profiling of alveolar rhabdomyosarcoma reveals RAS pathway inhibitors as cell-fate hijackers with therapeutic relevance | Science Advances
![Novel Class IIa-Selective Histone Deacetylase Inhibitors Discovered Using an in Silico Virtual Screening Approach | Scientific Reports Novel Class IIa-Selective Histone Deacetylase Inhibitors Discovered Using an in Silico Virtual Screening Approach | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-017-03417-1/MediaObjects/41598_2017_3417_Fig1_HTML.jpg)
Novel Class IIa-Selective Histone Deacetylase Inhibitors Discovered Using an in Silico Virtual Screening Approach | Scientific Reports
![Borinostats: solid-phase synthesis of carborane-capped histone deacetylase inhibitors with a tailor-made selectivity profile - Chemical Science (RSC Publishing) DOI:10.1039/D1SC02268G Borinostats: solid-phase synthesis of carborane-capped histone deacetylase inhibitors with a tailor-made selectivity profile - Chemical Science (RSC Publishing) DOI:10.1039/D1SC02268G](https://pubs.rsc.org/image/article/2021/SC/d1sc02268g/d1sc02268g-f1_hi-res.gif)
Borinostats: solid-phase synthesis of carborane-capped histone deacetylase inhibitors with a tailor-made selectivity profile - Chemical Science (RSC Publishing) DOI:10.1039/D1SC02268G
![Molbank | Free Full-Text | N4-(2-Amino-4-fluorophenyl)-N1-(3-{2-[2-(3-{[2-(2,6-dioxo-3-piperidyl)-1,3-dioxoisoindolin-4-yl]amino}propoxy)ethoxy]ethoxy}propyl)terephthalamide Molbank | Free Full-Text | N4-(2-Amino-4-fluorophenyl)-N1-(3-{2-[2-(3-{[2-(2,6-dioxo-3-piperidyl)-1,3-dioxoisoindolin-4-yl]amino}propoxy)ethoxy]ethoxy}propyl)terephthalamide](https://pub.mdpi-res.com/molbank/molbank-2022-M1501/article_deploy/html/images/molbank-2022-M1501-ag.png?1669188638)
Molbank | Free Full-Text | N4-(2-Amino-4-fluorophenyl)-N1-(3-{2-[2-(3-{[2-(2,6-dioxo-3-piperidyl)-1,3-dioxoisoindolin-4-yl]amino}propoxy)ethoxy]ethoxy}propyl)terephthalamide
![Discovery of STAT3 and Histone Deacetylase (HDAC) Dual-Pathway Inhibitors for the Treatment of Solid Cancer | Journal of Medicinal Chemistry Discovery of STAT3 and Histone Deacetylase (HDAC) Dual-Pathway Inhibitors for the Treatment of Solid Cancer | Journal of Medicinal Chemistry](https://pubs.acs.org/cms/10.1021/acs.jmedchem.1c00136/asset/images/large/jm1c00136_0002.jpeg)
Discovery of STAT3 and Histone Deacetylase (HDAC) Dual-Pathway Inhibitors for the Treatment of Solid Cancer | Journal of Medicinal Chemistry
![ChiIL Live Shows: REVIEW: Sister Act at Metropolis Performing Arts Centre On Stage Through August 27th, 2022 ChiIL Live Shows: REVIEW: Sister Act at Metropolis Performing Arts Centre On Stage Through August 27th, 2022](https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEhU73-JZm5uOv7e9tv6kBA_-az9gVXkdL5ktqatPj15-SNKoAJdSeJKUI8-0nFfSDbjnb_MiHNygwVGLoluXjvcwIMIDKiOXnfoFNQB0Ky-DCSUG8jcSqtGZJMaSV5krU5C56MIYe9EZ_NQyf_0-K67Q5oqKdytIdAAKEZZqdN_bSM4JYnSI_kmEih8/s2048/288036982_10159631568255169_3983907589764053381_n.jpg)
ChiIL Live Shows: REVIEW: Sister Act at Metropolis Performing Arts Centre On Stage Through August 27th, 2022
![Discovery of STAT3 and Histone Deacetylase (HDAC) Dual-Pathway Inhibitors for the Treatment of Solid Cancer | Journal of Medicinal Chemistry Discovery of STAT3 and Histone Deacetylase (HDAC) Dual-Pathway Inhibitors for the Treatment of Solid Cancer | Journal of Medicinal Chemistry](https://pubs.acs.org/cms/10.1021/acs.jmedchem.1c00136/asset/images/large/jm1c00136_0019.jpeg)
Discovery of STAT3 and Histone Deacetylase (HDAC) Dual-Pathway Inhibitors for the Treatment of Solid Cancer | Journal of Medicinal Chemistry
Discovery of Selective Histone Deacetylase 6 Inhibitors Using the Quinazoline as the Cap for the Treatment of Cancer | Journal of Medicinal Chemistry
![Azetidin-2-one-based small molecules as dual hHDAC6/HDAC8 inhibitors: Investigation of their mechanism of action and impact of dual inhibition profile on cell viability - ScienceDirect Azetidin-2-one-based small molecules as dual hHDAC6/HDAC8 inhibitors: Investigation of their mechanism of action and impact of dual inhibition profile on cell viability - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0223523422003117-ga1.jpg)
Azetidin-2-one-based small molecules as dual hHDAC6/HDAC8 inhibitors: Investigation of their mechanism of action and impact of dual inhibition profile on cell viability - ScienceDirect
![Development of novel tetrahydroisoquinoline-hydroxamate conjugates as potent dual SERDs/HDAC inhibitors for the treatment of breast cancer - ScienceDirect Development of novel tetrahydroisoquinoline-hydroxamate conjugates as potent dual SERDs/HDAC inhibitors for the treatment of breast cancer - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0223523421007194-ga1.jpg)